Mission Bio

Cell and gene therapies can change the lives of patients with fatal or chronic illnesses, but they’re inherently complex and difficult to characterize. Deep analytical characterization is vital for untangling underlying variation in CGTs and key to developing safe and efficacious treatments that improve patients’ lives.

Mission Bio is thrilled to introduce the Tapestri Cell & Gene Therapy Solutions, enabling deep analytical characterization of CGTs for quicker, more efficient workflows. Learn more: https://bit.ly/3DOshkD

Just released – Journal Citation Reports from Clarivate, 2021, Impact Factors for the AACR Journals. Check out these exciting publications and more here:

https://bit.ly/3nu57Lp

The International Society for Stem Cell Research and the American Society of Gene and Cell Therapy are partnering to host a cutting-edge program on the latest advances in regenerative medicine As a premier sponsor of this virtual event, we are excited to meet fellow scientists and industry experts to discuss how we can enable their success. Join us to learn about implementing single-cell analysis in advanced therapy development and our Pharma Assay Development services. Be sure to also tune into Mission Bio’s exclusive 10-minute Innovation Showcase that will be streamed live during the event

Register Here: https://bit.ly/38Te1tf

ISSCR/ASGCT 2021 International Symposium ISSCR ASCGT 2021 International Symposium

Mission Bio has raised $43,278 in the last 4 years for the Leukemia and Lymphoma Society’s Light the Night event. Our 2021 Team Goal is to raise $25,000. Together we will

Learn more about how to participate in Light the Night: https://bit.ly/3jS6CAx

The International Society for Stem Cell Research and the American Society of Gene and Cell Therapy are partnering to host a cutting-edge program on the latest advances in regenerative medicine

As a premier sponsor of this virtual event, we are excited to meet fellow scientists and industry experts to discuss how we can enable their success. Join us to learn about implementing single-cell analysis in advanced therapy development and our Pharma Assay Development services. Be sure to also tune into Mission Bio’s exclusive 10-minute Innovation Showcase that will be streamed live during the event

Register Here: https://bit.ly/3l4pzPU

ISSCR/ASGCT 2021 International Symposium ISSCR ASCGT 2021 International Symposium

Register today for the 2021 SOHO Annual Meeting. The program will focus on cutting-edge advances and practical clinical applications, with special emphasis on novel biological and therapeutic approaches, for patients with hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases

Mission Bio will be attending virtual event. Stop by our booth to schedule 1-on-1 meetings with our team and see the latest Mission Bio has to offer

Register Here: https://bit.ly/3n2rp6G

Register today for the 2021 SOHO Annual Meeting. The program will focus on cutting-edge advances and practical clinical applications, with special emphasis on novel biological and therapeutic approaches, for patients with hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases

Mission Bio will be attending virtual event. Stop by our booth to schedule 1-on-1 meetings with our team and see the latest Mission Bio has to offer

Register Here: https://bit.ly/3BCTTIa

In case you missed it, we just launched our New Learning Center! Mission Bio is committed to helping you learn about single-cell DNA sequencing and multi-omics and how these exciting technologies are advancing medical science.

Read Chapter Four: https://bit.ly/2WNE4z3

In case you missed it, we just launched our New Learning Center! Mission Bio is committed to helping you learn about single-cell DNA sequencing and multi-omics and how these exciting technologies are advancing medical science.

Read Chapter Three: https://bit.ly/3DEmKxG

We just launched our New Learning Center! Mission Bio is committed to helping you learn about single-cell DNA sequencing and multi-omics and how these exciting technologies are advancing medical science.

Read Chapter Two: https://bit.ly/38p9BKu

Mission Bio is proud to announce our New Learning Center! We are committed to helping you learn about single-cell DNA sequencing and multi-omics and how these exciting technologies are advancing medical science.

Enjoy exploring our education hub!

Read Chapter One: https://bit.ly/3DFuAXU

Happy Friday from the Mission Bio Team!

Happy Women's Equality Day from Mission Bio!

Learn more about how the Woman of Mission Bio (WOMO) group started and some of the activities that have been happening this year: https://bit.ly/38ebNnN

Leveraging Mission Bio’s Single-cell Tapestri Platform, a study published in Nature by Dr. Douglas A. Marchuk and Daniel Snellings at Duke University School of Medicine uses single-cell DNA sequencing on frozen human cerebral cavernous malformations (CCM) lesion tissue samples to unveil the genetic architecture of CCMs in familial and sporadic CCMs.

Technology Networks interviewed Douglas Marchuk, PhD and Daniel Snellings to find out more about the current state and future prospects of CCM treatment.

Read more about the interview: https://bit.ly/3jimLPu

In a study published in Blood Advances, Agios Pharmaceuticals used high-throughput single-cell DNA analysis to characterize complex therapy resistance mechanisms and generate actionable hypotheses for improving drug trials.

Read more: https://bit.ly/2WrtPRp

Happy Friday from the Mission Bio Team!

Leveraging the Tapestri Platform, Dr. Cathy Smith and team at University of California, San Francisco (UCSF) have been using high-throughput single-cell DNA analysis to answer unprecedented questions about AML therapy resistance.

Read more: https://bit.ly/2WciFzH

“We take those hats off in the meetings, and we are all regular women. It doesn’t matter your role, we want people to participate as much as possible” - Samantha Mason, Mission Bio’s Director of Software Products

This week on Drop-Lits, Samantha Mason spoke to us about how the Woman of Mission Bio (WOMO) group started and some of the activities that have been happening this year.

Learn more about WOMO: https://bit.ly/3mfg6HQ

How will you use sequencing in your research?

Join us on August 18-19 for a virtual meeting hosted with American Association for Cancer Research (AACR) to explore the biology of Clonal Hematopoiesis (CH), causative mutations, population-level studies of CH, and its clinical impact

Register at https://bit.ly/3iR8d9w

Registration | Clonal Hematopoiesis | AACR Meetings Please Note: All session times for the AACR Virtual Meeting: Clonal Hematopoiesis are U.S. Eastern Daylight Time (EDT). Attendee registration includes access to all sessions presented during the live August 18-19, 2021, program and to the on-demand recordings. On-demand materials will be available...

In a study published in Blood Advances, Agios Pharmaceuticals used high-throughput single-cell DNA analysis to characterize complex therapy resistance mechanisms and generate actionable hypotheses for improving drug trials.

Read more: https://bit.ly/3m955HR

How will you use sequencing in your research?

Join us on August 18-19 for a virtual meeting hosted with American Association for Cancer Research (AACR) to explore the biology of Clonal Hematopoiesis (CH), causative mutations, population-level studies of CH, and its clinical impact

Register at https://bit.ly/3ADmY5P

Registration | Clonal Hematopoiesis | AACR Meetings Please Note: All session times for the AACR Virtual Meeting: Clonal Hematopoiesis are U.S. Eastern Daylight Time (EDT). Attendee registration includes access to all sessions presented during the live August 18-19, 2021, program and to the on-demand recordings. On-demand materials will be available...

“Leadership is about being present, engaging with an open mind and connecting with your team” - Yan Zhang, CEO of Mission Bio

Yan recently published an article on Forbes about the importance of meeting and listening to employees

Read more: https://bit.ly/37DzXrS

The transition from studying plant transcriptomes at the tissue level to the level of individual cells was an issue for plant science.

To overcome this barrier, Tapestri was used to identify gene expression levels at the small cell population.

Read more: https://bit.ly/3s8mAcw

A study published by Cancer Discovery covers the comprehensive serial genotyping of AML specimens from patients treated with the selective FLT3 inhibitor gilteritinib.

This study demonstrates that complex, heterogeneous patterns of clonal selection and evolution mediate clinical resistance to tyrosine kinase inhibition in FLT3-mutated AML.

Read more: https://bit.ly/3xI9XpE

In a study published by Cancer Discovery, McMahon and colleagues indicate that emergence of multiple clones, each with distinct mechanisms of resistance, is a common finding at secondary failure of single-agent-targeted therapies for relapsed leukemias

Read more: https://bit.ly/3jGe4gY

To celebrate Cancer Discovery’s 10 year anniversary, Mission Bio will be featuring Cancer Discovery publications on our socials this week!

The first featured publication, “V211D Mutation in MEK1 Causes MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer,” reports the emergence of the novel MEK1 gatekeeper mutation in a patient with BRAF colon cancer.

Read more: https://bit.ly/3jAuEyR

Happy 10 Year Anniversary to Cancer Discovery!

To celebrate, we will highlight some of Cancer Discovery’s publications on our social pages next week

For the 10 year anniversary, Cancer Discovery’s Editors-in-Chief, Lewis Cantley, PhD, FAACR, and Luis Diaz, MD, were interviewed about the journal’s origins, accomplishments, and future.

Read more: https://bit.ly/3CnIoWo

How will you use sequencing in your research? In this webinar hosted with Van Andel Institute we’ll discuss
Cancer-like Mechanism Of Cerebral Cavernous Malformations.

Register at https://bit.ly/3eXlZVA

Welcome! You are invited to join a webinar: Discovering The Cancer-like Mechanism Of Cerebral Cavernous Malformations Using Single-Cell DNA Sequencing. After registering, you will receive a confirmation email about joining the webinar. Please join us on Tuesday, 10 August at 3:30 PM EDT for a virtual seminar with the Van Andel Institute to learn about single-cell DNA + protein sequencing. How will you use single-cell sequencing in your research? Topics include: • General Tapestri Overview • Hematology Applications • Dan Snel...

“You have cancer.”

Ten years ago, 15-year-old Manuel’s life was forever changed by these three words.

Today, he is no longer a patient but a provider as he works alongside the very doctors and nurses who saved his life.

Read about Manuel’s inspiring journey: https://bit.ly/3yr8ogW